Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 3
1972 3
1973 2
1974 3
1975 3
1977 3
1978 1
1980 1
1981 2
1982 2
1983 1
1984 2
1985 1
1986 1
1987 4
1988 2
1989 4
1990 8
1991 20
1992 17
1993 12
1994 19
1995 7
1996 10
1997 1
1998 6
1999 4
2000 2
2001 6
2002 4
2003 3
2004 6
2005 3
2006 4
2007 6
2008 10
2009 11
2010 5
2011 4
2012 3
2013 2
2014 3
2015 1
2016 3
2017 3
2018 2
2019 5
2020 3
2021 4
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year

Filters applied: . Clear all
Page 1
The epidemiology and etiology of azoospermia.
Cocuzza M, Alvarenga C, Pagani R. Cocuzza M, et al. Among authors: pagani r. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):15-26. doi: 10.6061/clinics/2013(sup01)03. Clinics (Sao Paulo). 2013. PMID: 23503951 Free PMC article. Review.
Editorial Commentary.
Pagani RL, Ohlander S. Pagani RL, et al. Urol Pract. 2022 Jul;9(4):329-330. doi: 10.1097/UPJ.0000000000000303.01. Epub 2022 Apr 18. Urol Pract. 2022. PMID: 37145783 No abstract available.
HER2-targeted therapies for salivary gland cancers.
Filippini DM, Pagani R, Tober N, Lorini L, Riefolo M, Molinari G, Burato A, Alfieri S, Bossi P, Presutti L. Filippini DM, et al. Among authors: pagani r. Oral Oncol. 2024 Jan;148:106612. doi: 10.1016/j.oraloncology.2023.106612. Epub 2023 Nov 27. Oral Oncol. 2024. PMID: 38016228 Free article. Review.
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease.
Caserta C, Nucera S, Barcella M, Fazio G, Naldini MM, Pagani R, Pavesi F, Desantis G, Zonari E, D'Angiò M, Capasso P, Lombardo A, Merelli I, Spinelli O, Rambaldi A, Ciceri F, Silvestri D, Valsecchi MG, Biondi A, Cazzaniga G, Gentner B. Caserta C, et al. Among authors: pagani r. Leukemia. 2023 Oct;37(10):1994-2005. doi: 10.1038/s41375-023-02009-5. Epub 2023 Aug 28. Leukemia. 2023. PMID: 37640845
244 results